AI Revolutionizes IVF in India

Infertility clinic chain Gaudium IVF has launched an AI-led infertility treatment in India, incorporating advanced embryology tools into its clinical practice. This significant development follows the company's recent listing as the country's first publicly traded IVF chain.

Union Minister Nitin Gadkari inaugurated the new AI integration, emphasizing the increasing importance of technology-driven innovation across various sectors. The initiative is a collaboration with AI tool suite IVF 2.0, founded by embryologists Jacques Cohen and Alejandro Chave.

Gaudium IVF is utilizing AI-powered systems, specifically SiD (Sperm Identification Device) and ERICA (Embryo Ranking Intelligent Classification Assistant). SiD analyzes sperm movement for optimal selection, while ERICA ranks embryos based on data-driven analysis of blastocyst images.

These non-invasive AI tools are designed to support clinical decision-making, improve precision in IVF procedures, and potentially enhance fertilisation and blastocyst development rates. The company anticipates that this will reduce the need for repeat treatment cycles, thereby easing the emotional and financial strain on patients seeking fertility care.